Literature DB >> 18508415

Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains.

Jelena Ivancic-Jelecki1, Maja Santak, Dubravko Forcic.   

Abstract

The mumps virus (MuV) molecular evolution is characterized by the co-circulation of numerous distinct strains. Standardized phylogenetic analyses based on the nucleotide sequences of the SH gene are important for mumps surveillance, but lack the information regarding antigenic properties. So far, the location of antigenic epitopes has been determined for two MuV proteins, the hemagglutinin-neuraminidase (HN) and the nucleocapsid (N) protein. We performed multiple sequence comparisons of putative HN and N protein sequences in order to describe their diversity and plasticity, and to determine the level of similarity between vaccine and wild-type strains. The results of full-length HN or N protein phylogeny showed that MuV strains form a number of differing clades which are in concordance with grouping obtained by standard MuV genotyping. When vaccine strains are compared to all wild-type strains, the highest mean percentage of amino acid differences in both HN and N protein analysis was found for Jeryl Lynn 5 and Jeryl Lynn 2 strains while the lowest value was obtained for Leningrad-3 and L-Zagreb strains. When only 3 antigenic regions of the HN protein, comprising 45 amino acids in total, were investigated, the diversity is considerably diminished: 51.5% of all putative HN proteins show identical sequences (including those of vaccine strains L-Zagreb, Leningrad-3, Hoshino and Urabe). Another 26.5% proteins (including Miyahara vaccine strain) differ in only one amino acid, while the others differ in two to five amino acids from the most common sequence. Jeryl Lynn 2 and Jeryl Lynn 5 strains differ in four amino acids each. N protein antigenic sites have been mapped within its hypervariable C-terminus. Our results indicate that there might be genotype-specific amino acids residing in this antigenic region. The results of our study present the background information for investigations of MuV heterogeneity and antigenic diversity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508415     DOI: 10.1016/j.meegid.2008.04.007

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

1.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Exploring the Mumps Virus Glycoproteins: A Review.

Authors:  Jasmine Rae Frost; Saba Shaikh; Alberto Severini
Journal:  Viruses       Date:  2022-06-18       Impact factor: 5.818

3.  Streamlined Whole-Genome Sequencing of Mumps Virus for High-Resolution Outbreak Analysis.

Authors:  Patrick Bryant; Haley Caldwell; Daryl M Lamson; Tugba Yildirim; Kirsten St George
Journal:  J Clin Microbiol       Date:  2021-11-10       Impact factor: 11.677

4.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

5.  An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland.

Authors:  L J Willocks; D Guerendiain; H I Austin; K E Morrison; R L Cameron; K E Templeton; V R F DE Lima; R Ewing; W Donovan; K G J Pollock
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

6.  In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.

Authors:  Sarah M Connaughton; Jun X Wheeler; Eva Vitková; Philip Minor; Silke Schepelmann
Journal:  Vaccine       Date:  2015-07-15       Impact factor: 3.641

Review 7.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

8.  Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis.

Authors:  E Jane Homan; Robert D Bremel
Journal:  Hum Vaccin Immunother       Date:  2013-11-25       Impact factor: 3.452

9.  Importation of Mumps Virus Genotype K to China from Vietnam.

Authors:  Wei Liu; Lili Deng; Xianyu Lin; Ximing Wang; Yuyan Ma; Qiuyun Deng; Xiaohua Xue; Ge Zhong; Li Jin
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883

Review 10.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.